Publication of 2 new articles implying SOLADIS
Two of the projects our team are working for our pharma clients have been published !
With those 2 articles, Soladis records its 95th and 96th publications.
« Basophils from allergic patients are neither hyper-responsive to activation signals nor hypo-responsive to inhibition signals. », a study published in the Journal of Allergy and Clinical Immunology.
and
« Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines. », published in The Journal of Infectious Diseases.
Soladis - France (siège)
6-8 rue Bellecombe
69006 LYON - FRANCE
Tél: +33(0)4.72.83.86.70
Soladis GmbH - Suisse
Lange Gasse 15
CH-4052 Basel
Phone: +41(0)58.258.15.80
Soladis Inc. - USA
185 Alewife Brook Pkwy, Unit 210
Cambridge, MA 02138-1100
Phone: +1(857).675.1189
Nous contacter
RECHERCHER